Piedmont Lithium Inc. - Sponsored ADR (PLL) shares soared 11.5% in the last trading session to close at $7.49. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 9.6% gain over the past four weeks.Shares of Piedmont Lithium gained, driven by the increase in price of lithium. Even though lithium has fallen 24.9% in a year's time, it has improved 7.4% in a month.This company is expected to post quarterly loss of $0.38 per share in its ...

Energy Fuels (UUUU) shares ended the last trading session 10.7% higher at $7.76. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 20.9% gain over the past four weeks.Shares of Energy Fuels gained following the announcement that the Pinyon Plain uranium mine in Arizona is significantly outperforming earlier production estimates. Pinyon Plain mine output was driven by high grades averaging 3.51% in June and 2.23% in t ...

Turning Point Brands (TPB) shares soared 5.1% in the last trading session to close at $78.39. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 1.4% loss over the past four weeks.Turning Point Brands shares are gaining on optimism surrounding growth in the modern oral segment, supported by expanding nicotine pouch sales and increasing market penetration. The company’s focus on brand building, retail partnerships, and operational en ...

Shopify (SHOP) closed at $115.01 in the latest trading session, marking a -1.48% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.4%. At the same time, the Dow lost 0.98%, and the tech-heavy Nasdaq gained 0.18%. Prior to today's trading, shares of the cloud-based commerce company had gained 7.72% outpaced the Computer and Technology sector's gain of 6.34% and the S&P 500's gain of 4.97%.Investors will be eagerly watching for the performance of Shopify in its upcomin ...

Hancock Whitney (HWC) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.24%. A quarter ago, it was expected that this holding company of Whitney Bank and Hancock Bank would post earnings of $1.28 per share when it actually produced earnings of $1.38, delivering a surprise of +7.81%.O ...

Core Viewpoint - Investors are seeking growth stocks that can deliver above-average growth and exceptional returns, but identifying such stocks is challenging due to inherent volatility and risks [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system aids in identifying promising growth stocks by analyzing real growth prospects beyond traditional metrics [2] - Harmony Biosciences Holdings, Inc. (HRMY) is highlighted as a recommended stock with a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is crucial for investors, with double-digit growth being a strong indicator of future stock price gains [3] - Harmony Biosciences has a historical EPS growth rate of 11.7%, with projected EPS growth of 22.5% this year, surpassing the industry average of 19.1% [4] Group 3: Cash Flow Growth - High cash flow growth is essential for growth-oriented companies, allowing them to fund new projects without external financing [5] - Harmony Biosciences has a year-over-year cash flow growth of 10%, significantly higher than the industry average of -4.7% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 25.7%, compared to the industry average of 4.1% [6] Group 4: Earnings Estimate Revisions - Positive trends in earnings estimate revisions correlate strongly with near-term stock price movements [7] - Current-year earnings estimates for Harmony Biosciences have been revised upward, with the Zacks Consensus Estimate increasing by 0.2% over the past month [8] Group 5: Overall Assessment - Harmony Biosciences has achieved a Growth Score of B and a Zacks Rank 2, indicating positive earnings estimate revisions and potential for outperformance [9]

Investors might want to bet on Penguin Solutions, Inc. (PENG) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this company, should get reflected in its stock price. After all, empirical research shows a strong correlation betw ...

T. Rowe Price (TROW) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this financial services firm, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings est ...

Vertex (VERX) shares rallied 5% in the last trading session to close at $36.21. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 6.6% loss over the past four weeks.Vertex is benefiting from the growing adoption of e-invoicing mandates and cloud migration in the enterprise sector.This company is expected to post quarterly earnings of $0.14 per share in its upcoming report, which represents a year-over-year chan ...

Investors might want to bet on Marex Group PLC (MRX) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individua ...